Lilly Buys Psychedelics Maker Atai Beckley for $2.8B
Eli Lilly unveils a landmark $2.8 billion cash deal to acquire Atai Beckley, aiming to push a DMT-like therapy for tr...
Wealth planning is crucial for families. Explore tailored strategies that can help secure your family's financial future.
16,354 articlesEli Lilly unveils a landmark $2.8 billion cash deal to acquire Atai Beckley, aiming to push a DMT-like therapy for tr...
A leading manager weighs the case for broad crypto exposure after investors rejected crypto basket ETFs. Early demand...
A perplexing Friday drop in Coca-Cola stock raised questions about cybersecurity, earnings risk, and how to react to ...
The S&P 500 exhibits a pronounced tech tilt as AI leaders drive gains. But a rising concentration risk could redefine...
XRP remains a top topic in 2026 as markets weigh its speed-driven use against regulatory risk and liquidity dynamics....
Apple is leaning into a capital-light AI model that runs on-device and with trusted partners. This story explains why...
MSCI stock is facing a sharp move lower after quarterly results and an strategic shift. This article explains the dri...
As AI workloads surge, Celestica could play a pivotal role in data-center hardware. This guide breaks down the busine...
Figma reports Q4 2025 revenue of $303.8 million, up 40% year over year, pushing annual revenue over the $1 billion ma...
Bitcoin breaks a 12-year trend against gold, signaling a shift in risk sentiment as quantum-era concerns enter mainst...
A sweeping government push to secure rare earths could reshape the landscape for USA Rare Earth. This guide breaks do...
Palantir has surprised and divided investors with big moves and bold AI promises. This guide explains what to watch, ...